Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa

Author:

Murphy Ronan A.1ORCID,Coates Matthew1,Thrane Sophia2,Sabnis Akshay3,Harrison James4,Schelenz Silke5,Edwards Andrew M.3ORCID,Vorup-Jensen Thomas2,Davies Jane C.16

Affiliation:

1. National Heart and Lung Institute, Imperial College London, London, United Kingdom

2. Department of Biomedicine, Aarhus University, Aarhus, Denmark

3. MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom

4. Cycle Pharmaceutical Ltd., Cambridge, United Kingdom

5. King’s College Hospital NHS Foundation Trust, KingsPath Clinical Diagnostics Pathology Services, London, United Kingdom

6. Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom

Abstract

The antimicrobial resistance crisis urgently requires solutions to the lost efficacy of antibiotics. The repurposing of drugs already in clinical use, with strong safety profiles, as antibiotic adjuvants to restore the efficacy of antibiotics is an important avenue to alleviating the resistance crisis.

Funder

Cystic Fibrosis Trust

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Reference75 articles.

1. Charman S McClenaghan E Cosgriff R Lee A Carr S. 2019. UK Cystic Fibrosis Registry annual data report 2018. Cystic Fibrosis Trust London United Kingdom.

2. Origins of Cystic Fibrosis Lung Disease

3. Cystic fibrosis

4. Cystic fibrosis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3